Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04503694 |
| Title | Neoadjuvant Regorafenib in Combination With Nivolumab and Short-course Radiotherapy in Intermediate-risk, Stage II-III Rectal Cancer (REGINA) |
| Acronym | REGINA |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Jules Bordet Institute |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | BEL |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Institut Jules Bordet | Anderlecht | 1070 | Belgium | Details | ||
| Chirec Delta | Brussels | 1160 | Belgium | Details | ||
| Cliniques Universitaires Saint-Luc | Brussels | 1200 | Belgium | Details | ||
| UZAntwerpen | Edegem | 2650 | Belgium | Details | ||
| UZ Gent | Ghent | 9000 | Belgium | Details | ||
| Grand Hopital de Charleroi | Gilly | 6060 | Belgium | Details | ||
| AZ Groeninge | Kortrijk | 8500 | Belgium | Details | ||
| CHU Ambroise Paré | Mons | 7000 | Belgium | Details | ||
| CHR Namur | Namur | 5000 | Belgium | Details |